STOCK TITAN

Inspire Medical Systems, Inc. to Report Second Quarter 2020 Financial Results on August 4, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Inspire Medical Systems, Inc. (NYSE: INSP) plans to release its second quarter 2020 financial results on August 4, following the market close. A conference call will start at 5:00 PM ET to discuss the results and recent business developments. Inspire specializes in innovative, minimally invasive solutions for obstructive sleep apnea, including its FDA-approved neurostimulation technology. For information, visit www.inspiresleep.com.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, July 07, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the second quarter 2020 after the close of trading on Tuesday, August 4.  Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

100%; border-collapse:collapse !important;">
Tuesday, August 4th @ 5:00 p.m. Eastern Time:
25%; width:25%; min-width:25%;">Domestic: 75%; width:75%; min-width:75%;">877-407-0792
International: 201-689-8263
Conference ID: 13706002
Webcast: http://public.viavid.com/index.php?id=140429

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989

 


FAQ

When will Inspire Medical Systems release its second quarter 2020 financial results?

Inspire Medical Systems will release its second quarter 2020 financial results on August 4, 2020.

What time is the Inspire Medical Systems conference call on August 4, 2020?

The conference call is scheduled for 5:00 PM Eastern Time on August 4, 2020.

How can I access the Inspire Medical Systems conference call?

You can access the Inspire Medical Systems conference call by calling 877-407-0792 domestically or 201-689-8263 internationally.

What is the purpose of Inspire Medical Systems' conference call on August 4, 2020?

The conference call will discuss financial results and recent business developments.

What technology does Inspire Medical Systems offer for obstructive sleep apnea?

Inspire Medical Systems offers a proprietary FDA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.

Inspire Medical Systems, Inc.

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

5.29B
29.97M
1.95%
111.52%
6.38%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
GOLDEN VALLEY